Risk Of Developing Liver Cancer After HCV Treatment

▼
Showing posts with label HCV agents/drug interactions. Show all posts
Showing posts with label HCV agents/drug interactions. Show all posts
Saturday, November 3, 2018

Minireview - Era of direct acting anti-viral agents for the treatment of hepatitis C

›
World J Hepatol. Oct 27, 2018; 10(10): 670-684 Published online Oct 27, 2018. doi: 10.4254/wjh.v10.i10.670 The different DAAs with thei...
Friday, October 26, 2018

Hepatitis C - Potential drug‐drug interactions between DAAs and concomitant medications

›
Comorbidities, concomitant medications and potential drug‐drug interactions with interferon‐free direct‐acting antiviral agents in hepatitis...
Friday, September 28, 2018

Cardiovascular Risk Management and Hepatitis C: Combining Drugs

›
Cardiovascular Risk Management and Hepatitis C: Combining Drugs Elise J. SmoldersPeter J. G. ter HorstSharon WoltersDavid M. Burger Elise J....
Tuesday, February 6, 2018

Podcast - Referring, and Managing Patients with HCV

›
Consultant360.com Published - January 26, 2018 Dr. Jorge Herrera, director of the Section of Hepatology and professor of Internal Medic...
Thursday, November 30, 2017

Drug-drug interactions in hepatitis C virus treatment: Do they really matter?

›
Clinical Liver Disease Clinical Liver Disease is an official digital educational learning resource from the American Association for the ...
Monday, November 13, 2017

Labeling for Several HCV Drugs Updated With New Drug Interactions

›
Review Labeling for Several HCV Drugs Updated With New Drug Interactions Specifically, the prescribing information for Viekira Pak (ombi...
Tuesday, April 11, 2017

Toxicity and risks from drug-to-drug interactions of new antivirals for chronic hepatitis C

›
European Review for Medical and Pharmacological Sciences Toxicity and risks from drug-to-drug interactions of new antivirals for chronic ...
Wednesday, March 1, 2017

Hepatitis C - Real-life data on potential drug-drug interactions in patients undergoing interferon-free DAAs

›
Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with i...
Monday, September 26, 2016

A Review of Daclatasvir Drug-Drug Interactions

›
Review article A Review of Daclatasvir Drug-Drug Interactions. Garimella T, et al. Adv Ther. 2016 Adv Ther. 2016 Sep 23. [Epub ahead of ...
Sunday, July 14, 2013

Meeting Report - 8th Hepatitis Pharmacology Workshop

›
Produced by www.hep-druginteractions.org Meeting Report - 8th Hepatitis Pharmacology Workshop, Cambridge, USA. Posted Thursday 11 July...